A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
Metformin is the first line drug for patients diagnosed with type-2 diabetes; however, the impact of different treatment escalation strategies after metformin failure has thus far not been investigated in a real world situation. The registry described herein goes some way to clarifying treatment out...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
03 February 2015
|
| In: |
Cardiovascular diabetology
Year: 2015, Jahrgang: 14, Pages: 1-8 |
| ISSN: | 1475-2840 |
| DOI: | 10.1186/s12933-015-0172-9 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12933-015-0172-9
|
| Verfasserangaben: | Anselm K. Gitt, Peter Bramlage, Steffen Schneider and Diethelm Tschöpe |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1766111831 | ||
| 003 | DE-627 | ||
| 005 | 20230427034856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210811s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12933-015-0172-9 |2 doi | |
| 035 | |a (DE-627)1766111831 | ||
| 035 | |a (DE-599)KXP1766111831 | ||
| 035 | |a (OCoLC)1341420417 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gitt, Anselm Kai |d 1964- |e VerfasserIn |0 (DE-588)124753132 |0 (DE-627)365720836 |0 (DE-576)294482792 |4 aut | |
| 245 | 1 | 2 | |a A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy |c Anselm K. Gitt, Peter Bramlage, Steffen Schneider and Diethelm Tschöpe |
| 264 | 1 | |c 03 February 2015 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.08.2021 | ||
| 520 | |a Metformin is the first line drug for patients diagnosed with type-2 diabetes; however, the impact of different treatment escalation strategies after metformin failure has thus far not been investigated in a real world situation. The registry described herein goes some way to clarifying treatment outcomes in such patients. | ||
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Effectiveness | |
| 650 | 4 | |a Glucose | |
| 650 | 4 | |a Insulin | |
| 650 | 4 | |a Oral antidiabetic drugs | |
| 650 | 4 | |a Outcomes | |
| 650 | 4 | |a Strategies | |
| 700 | 1 | |a Bramlage, Peter |d 1969- |e VerfasserIn |0 (DE-588)122465040 |0 (DE-627)08196014X |0 (DE-576)256677980 |4 aut | |
| 700 | 1 | |a Schneider, Steffen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tschöpe, Diethelm |d 1958- |e VerfasserIn |0 (DE-588)1012943453 |0 (DE-627)662777344 |0 (DE-576)346211751 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular diabetology |d London : BioMed Central, 2002 |g 14(2015), Artikel-ID 13, Seite 1-8 |h Online-Ressource |w (DE-627)356593665 |w (DE-600)2093769-6 |w (DE-576)107015390 |x 1475-2840 |7 nnas |a A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy |
| 773 | 1 | 8 | |g volume:14 |g year:2015 |g elocationid:13 |g pages:1-8 |g extent:8 |a A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12933-015-0172-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210811 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 124753132 |a Gitt, Anselm Kai |m 124753132:Gitt, Anselm Kai |d 50000 |e 50000PG124753132 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1766111831 |e 3965175165 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"8 S."}],"relHost":[{"origin":[{"publisherPlace":"London","dateIssuedKey":"2002","publisher":"BioMed Central","dateIssuedDisp":"2002-"}],"id":{"zdb":["2093769-6"],"eki":["356593665"],"issn":["1475-2840"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cardiovascular diabetology","title_sort":"Cardiovascular diabetology"}],"disp":"A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapyCardiovascular diabetology","note":["Gesehen am 25.05.2020"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"356593665","language":["eng"],"pubHistory":["1.2002 -"],"part":{"volume":"14","text":"14(2015), Artikel-ID 13, Seite 1-8","extent":"8","year":"2015","pages":"1-8"}}],"name":{"displayForm":["Anselm K. Gitt, Peter Bramlage, Steffen Schneider and Diethelm Tschöpe"]},"origin":[{"dateIssuedDisp":"03 February 2015","dateIssuedKey":"2015"}],"id":{"eki":["1766111831"],"doi":["10.1186/s12933-015-0172-9"]},"note":["Gesehen am 11.08.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1766111831","language":["eng"],"person":[{"role":"aut","display":"Gitt, Anselm Kai","roleDisplay":"VerfasserIn","given":"Anselm Kai","family":"Gitt"},{"family":"Bramlage","given":"Peter","display":"Bramlage, Peter","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Schneider, Steffen","roleDisplay":"VerfasserIn","role":"aut","family":"Schneider","given":"Steffen"},{"given":"Diethelm","family":"Tschöpe","role":"aut","display":"Tschöpe, Diethelm","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy","title":"A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy"}]} | ||
| SRT | |a GITTANSELMREALWORLDC0320 | ||